GNKG-168

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameGNKG-168
Drug Alias NameCpG-ODNGNKG-168CpG-685
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChangchun Huapu Bio-Tech Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSbi Biotech Co Ltd
Active IndicationsN/A
Inactive IndicationsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A